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Abstract 
Synthesis and Characterization of Zinc-Doped Magnetic 
Nanoparticles for Diagnostic Studies 
M.Sc minithesis, Chemistry Department, University of the Western 
Cape 
G.R.J Allard 
In the present study we report the synthesis and characterization of iron oxide 
magnetic nanoparticles doped with zinc in an attempt to enhance the magnetic 
properties. The nanoparticles were prepared via the co-precipitation route and 
capped with 3-phosphonopropionic acid (3-PPA). The amount of zinc dopant was 
varied to yield nanoparticles with the general formula ZnxFe3-xO4 (x=0, 0.1, 0.2, 0.3, 
0.4). Characterization was carried out using high resolution transmission electron 
microscopy (HRTEM), X-ray diffraction spectroscopy (XRD), energy-dispersive X-
ray spectroscopy (EDS), Fourier transform infrared spectroscopy (FTIR), 
thermogravimetric analysis (TGA) and superconducting quantum interference device 
(SQUID) analysis. Results from HRTEM, XRD and SQUID confirm that doping 
took place and x=0.2 was found to be the doping limit for these nanoparticles with a 
maximum size of 10.73 nm and saturation magnetization of 73.37 emu/g. The EDS 
further confirmed successful doping with zinc, while FTIR and TGA confirmed 
successful capping with 3-PPA. Despite agglomeration at all doping levels, these 
nanoparticles show great potential for application in breast cancer diagnostic studies. 
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Chapter 1 
 
 
Chapter Overview 
Presented in this chapter is a summary of cancer, with mention of global statistics 
and a brief discussion of the current status of breast cancer according to the most 
recent statistics available. The diagnostic studies of breast cancer is the ultimate goal 
of this project. The general properties of iron oxide magnetic nanoparticles are also 
discussed. The remainder of the chapter includes the problem statement, aims and 
objectives of the current work. 
 
 
1. Introduction 
1.1 Background 
1.1.1 Cancer 
Cancer is defined as the uncontrolled growth and spread of aberrant cells 
1,2
. In 2012, 
this group of diseases was responsible for 8.2 million deaths across the globe. It is 
known to cause more deaths than malaria, tuberculosis and AIDS combined and 
every one in seven deaths is reported to be due to cancer related complications 
2
. The 
leading causes of cancer are related to dietary and behavioral problems which 
include the use of alcohol and tobacco, inadequate intake of vegetables and fruits, 
lack of exercise and high body mass index. Other causes include unprotected 
exposure to sunlight and UV radiation for extended periods of time, exposure to 
radiation and chemical carcinogens such as arsenic and asbestos 
3,4
. 
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In 2013, the International Agency for Research on Cancer (IARC) reported the 
global cancer statistics collected during 2012 
5
. Of all the known types of cancer, 
lung, breast and colorectum cancer were the most commonly diagnosed making up 
13%, 11.9% and 9.7% of the total respectively. 
 
A variety of diagnostic tests and procedures have been developed over the years 
6
. 
The type of test chosen is dependent on multiple factors such as the type of cancer, 
the age and the medical condition of the patient, previous test results and the severity 
of the symptoms seen in the patient. Examples of these tests include biopsies, which 
is the analysis of a tissue sample that could be malignant, and magnetic resonance 
imaging (MRI) in which high resolution computer generated images are obtained by 
exposure magnetic fields. Other techniques include the fecal occult blood test which 
investigates the presence of blood in a stool sample to ascertain if malignant growths 
are present in the digestive system, mammography, the use of X-rays to examine 
breast tissue for cancer, and ultrasound, where high frequency sound waves are used 
to detect irregularities in various kinds of tissue throughout the body. 
 
1.1.2 Breast Cancer 
The most common cancer diagnosed in women is breast cancer, affecting women in 
140 of 184 contries all over the world 
5
. The early diagnosis and prognosis of breast 
cancer patients in developed countries is mostly good, but the opposite is true in the 
case of developing countries 
2
. In 2012, the total number of newly diagnosed cases of 
breast cancer was close to 1.7 million with 521 900 deaths reported in the same year 
for breast cancer-related complications 
2
. Research has also shown that the number 
of breast cancer diagnoses have increased greatly from 2008 to 2012 
7
. 
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The symptoms of breast cancer are commonly described as a painless mass or lump 
in the breast. Diagnosis in developed countries is often made via mammogram, and 
well before other symptoms of the disease progress 
2
. 
 
1.1.3 Modern nanomaterials and biomedicine 
At present, nanomaterials have been intensively researched due to their size and 
large surface area, making them ideal candidates for biomedical applications such as 
imaging, diagnostics and treatment of diseases such as cancer 
8
. Materials such as 
carbon nanotubes (CNTs), graphene and nanodiamonds (NDs) are of interest due to 
their thermal, optical, mechanical and electrical properties that have led to their 
application in the syntheses of substrates for cell growth as well as nanoelectrodes 
9
. 
NPs that emit size-dependent electromagnetic radiation have also been used to obtain 
images of tumor sites and the delivery of drugs into diseased tissue 
10
. This is only a 
small portion of the great potential that nanomaterials possess for applications in 
biomedicine. 
 
1.2 Problem statement 
Comparing data from 2008 to 2012, it is clear that there is a rise in breast cancer 
across the globe. According to a press release from the IARC, developing countries 
going through economic and societal changes have a rise in their cancer burden due 
to lifestyle changes that bring about hormonal dietary, reproductive risk factors and 
in the four year time-frame, an increase of 20% in breast cancer incidence has been 
reported 
31
. This has created a need for more rapid and efficient diagnostic tools that 
can be made available to both developing and developed countries. 
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Therefore, the focus of this research is the development of a new method of 
preparing superparamagnetic Fe3O4 NPs of a high quality and improved magnetic 
and morphological properties through variation of the dopant concentration, making 
them ideal canditates for application in cancer diagnostics. 
 
1.3 Research aims and objectives 
The aim of this project is to synthesize and characterize zinc-doped iron oxide 
nanoparticles for diagnostic studies. 
 
Thus the objectives of this study are: 
1. To synthesize the nanoparticles using the co-precipitation route. 
2. To dope the nanoparticles with increasing levels of zinc while using 3-PPA 
as a surfactant. 
3. To use relevant microscopic and spectroscopic techniques to characterize the 
MNPs 
4. To bioconjugate the MNPs with a known breast cancer anti-body. 
5. To test the efficiency of the conjugated MNPs in targeting and diagnosis of 
breast cancer. 
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Chapter 2 
 
 
Chapter overview 
This chapter presents a review of literature describing the synthesis and biomedical 
applications of pure and transition metal doped magnetic nanoparticles. The review 
highlights several routes of syntheses, but focuses on the synthetic method relevant 
to the present work and gives detailed reviews of how the properties of the 
nanoparticles change with the inclusion of a dopant. This is followed by a review of 
the biomedical applications of iron oxide nanoparticles and the link to applications in 
breast cancer diagnostics and treatment. 
 
 
2. Literature Review 
2.1 Introduction 
2.1.1 General properties of MNPs 
Magnetic iron oxide nanoparticles (MNPs) have been researched intensively over the 
past decade due to their novel properties such as limited toxicity 
1
, simple detection 
and separation 
2
, low cost of production 
3
, and small size 
4
. Applications of magnetic 
nanoparticles include magnetic fluids 
5
, microwave absorption materials 
6
 catalysts 
7
, 
pigment 
8
, lithium ion batteries 
9
, magnetic separation 
10
 and environmental analysis 
11
. However, most research is based on biomedical applications, examples of these 
being hyperthermia treatments 
12
, magnetizable implants for drug delivery 
13
, 
contrast agents in magnetic resonance imaging (MRI) 
14
, stimuli-responsive systems 
1
, immobilization of enzymes 
15
 and nanoprobes for in-vivo imaging 
16
. The ideal 
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properties of MNPs required for these applications are narrow particle size 
distribution, a high magnetization values as well as particle sizes less than 100 nm. 
The agents used for coating the nanoparticles and providing the necessary surface 
chemistry are unique to the application and must be both biocompatible and non-
toxic while allowing targetable delivery within a specific region 
17
. 
 
These applications are, however, limited since problems with stability and 
dispersibility in polymer matrices and organic solvents are common, as well as low 
magnetization 
18,19
. The magnetic properties of a material are known to be dependent 
on the size of the domains within the material and the crystal structure 
20
. 
Superparamagnetism is observed in iron oxide nanoparticles at room temperature 
and particle sizes smaller than 128 nm, according to some reports 
19,21
. The 
saturation magnetization (Ms) decreases as the particle size is reduced to the 
nanoscale, and is due to surface effects and spin coating 
22,23
 as well as the synthetic 
route that is used 
20
. The Ms value for bulk magnetite (Fe3O4) is reported to be 85-
100 emu/g 
24
, while the Ms value for magnetite at the nanoscale is reported to be 
approximately 50 emu/g 
22
. This has resulted in most research on magnetic 
nanoparticles being focused on increasing the Ms value of nanoparticles enough to 
improve their efficiency in various applications. The crystal structure has been 
clearly described by Kristan et al. 
25
. Eight tetrahedral (A) sites occupied by Fe (III) 
ions and sixteen octahedral (B) sites occupied by Fe (II) ions make up each unit cell 
of the cubic inverse spinel structure of magnetite. All the A sites are reported to be 
magnetically equivalent, and the same is reported for the B sites. The inclusion of a 
dopant means that Fe (III) and Fe (II) ions are replaced by the dopant atoms, leading 
to a change in the superexchange interactions that give rise to the magnetic 
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properties of the MNPs 
20
. Transition metal dopants reported in literature include 
nickel, copper, barium, zinc and manganese 
26-30
 with zinc being the most reported 
dopant 
31-35
. This is most likely due to zinc having no effect on the already minimal 
toxicity of iron oxide nanoparticles used in biomedical applications since it is a 
health regulatory element in human body cells. 
 
2.2 Synthetic Procedures 
2.2.1 Introduction 
Reviews by Laurent et al. 
17
 and Lam et al. 
36
 describe as many as nine reported 
synthetic procedures for the preparation of magnetic nanoparticles. These include co-
precipitation, hydrothermal, microwave, microemulsion, sonolysis, thermal 
decomposition, electrospray, sol-gel and flow injection synthesis. It has been 
reported that the most preferred method for iron oxide magnetic nanoparticle 
synthesis at both laboratory and industrial levels is the co-precipitation method 
17
. 
This is due to the efficiency and simplicity of technique and the high yield of 
nanoparticles that can be obtained. 
 
2.2.2 Hydrothermal 
Due to the broad average particle size distribution of MNPs prepared using the co-
precipitation method, new synthetic routes have been devised as a means of yielding 
particles that are more monodisperse and also have a narrower size distribution. This 
synthetic route makes use of temperatures of 150 ˚C and above in a sealed reaction 
vessel to obtain MNPs from iron salts that have been dissolved in water. The 
reaction mixture is typically sealed in a teflon-lined autoclave to reach the pressure 
required for the reaction, and once the reaction time has been achieved, the system is 
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allowed to cool to room temperature, after which the particles that are obtained are 
washed and dried as necessary. The reaction temperature, time and choice of iron 
precursor can be varied to obtain the desired size of MNPs 
36
. A review published by 
Hayashi and Hakuta 
37
 gives a detailed discussion on the chemistry of hydrothermal 
synthesis of many metal oxide nanoparticles, including iron oxide nanoparticles with 
emphasis on the use of supercritical water as a means of controlling the physical and 
chemical properties of the nanoparticles and gives good insight to the potential of 
this route. Ge et al. 
38
 reported the synthesis of MNPs via the hydrothermal route at 
135 °C and 2 bar. The nanoparticles obtained were monodisperse had particle sizes 
ranging from 15 nm to 31 nm(Fig. 1) for the five different reaction conditions 
reported and saturation magnetization values ranging from 53.3 emu/g to 97.4 
emu/g. A report by Cai et al. 
39
 describes the synthesis of polyethyleneimine-coated 
MNPs prepared by the hydrothermal route. Synthesis was carried out at 134 °C at 2 
bar for 3 hours and the resulting particle sizes ranged from 11.5 nm 18.9 nm. 
 
Though the synthesis of high quality MNPs has been reported for this synthetic 
route, the somewhat harsh condition required for synthesis, namely the high 
temperatures and pressure, as well as the need for specialized equipment, make the 
co-precipitation route a better option due to its simplicity. 
 
2.2.3 Thermal decomposition 
Another technique that was developed to improve the monodispersity and provide a 
narrower size distribution is thermal decomposition of iron organic precursors at 
high temperatures. This technique was first introduced in the late 1970s in which a 
high boiling solvent such as decalin was used with iron carbonyl (Fe(CO)5) as the 
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precursor to produce the nanoparticles 
36
. Other iron organic precursors include iron 
acetylacetonate (Fe(acac)3) and (Fe(Cup)3). 
 
Yang et al. 
40
 reported the synthesis of MNPs via thermal decomposition, using seed 
crystals and iron (III) acetyl acetonate as precursors, 1,2-hexadecanediol as the 
solvent and oleic acid and oleyl-amine as the surfactants. The reaction was carried 
out at 200 °C for 2 hours and then 300 °C for 1 hour. Monodisperse MNPs were 
obtained with an average particle size of approximately 13.27 nm before ligand 
exchange with selected poly(amino acids) (Fig. 2). The saturation magnetization 
values ranged from 36.8 to 73.0 emu/g. Xiao et al. 
41
 reported on the synthesis of 
gadolinium-doped iron oxide nanoparticles prepared via thermal decomposition of 
iron (III) acetyl acetonate and gadolinium (III) acetyl acetonate in diethylene glycol 
(DEG). The reaction was carried out at 140 °C for 1 hour, followed by a further 8 
hours at 200 °C. Highly monodisperse undoped and doped nanoparticles were 
obtained with average particle sizes of approximately 4.29 nm and 4.74 nm 
respectively. Saturation magnetization values for the undoped and doped MNPs were 
34 emu/g and 25 emu/g respectively. 
 
Narrow size distributions and monodispered MNPs are obtainable via this route, 
however, the product cannot be dispersed in aqueous media. This is a requirement 
for biomedical applications, and would necessitate a ligand exchange step after 
synthesis, thus making synthesis via co-precipitation a more viable option. 
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Figure 1: HRTEM migrographs and particle size distributions reported by Ge et 
al 
27
. 
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Figure 2: HRTEM images of monodisperse poly(amino acid) coated MNPs 
reported by Yang et al 
40
. All scale bars are at 200 nm. 
 
2.2.4 Sonication 
This method of synthesis involves the formation of a high temperature hot spot 
created by the quick collapse of cavities that have been produced sonically 
17
. Three 
regions have been identified in this process, i) the interfacial liquid region which lies 
between the bulk solution and the cavitation bubbles, ii) the inner environment, made 
up of vaporization and pyrolyzation of water into OH and H radicals due to increased 
pressures and temperatures, bubbles and iii) the bulk solution which stays at room 
temperature 
25
. This reaction environment induces the formation of iron oxide 
nanoparticles from ferrous salt precursors 
17
. Shen et al. 
42
 employed this technique 
to prepare cysteine coated MNPs. Equal amounts of 0.2M L-cysteine and 0.2M iron 
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sulphate (FeSO4) were used as precursors. The reaction took place at room 
temperature, and the nanoparticles formed within 5 minutes of the addition of the 
reducing agent. Monodisperse nanoparticles with an average particle size of 15 nm 
were obtained and the saturation magnetization was reported to be 45 emu/g. The 
sonochemical synthesis of iron oxide MNPs for the targeted delivery of the drug 
chitosan has been reported 
43
. The loading of the drug was reported to increase with 
increasing frequency, however, characterization of the MNPs revealed the formation 
of maghemite and superparamagnetism was not observed. This is due to the 
oxidation of Fe(II) ions to Fe(III) by hydroxyl radicals produced in the collapse of 
cavities during synthesis. Based on what has been found in literature, the co-
precipitation method is preferred due to greater control of the product formed, 
specifically in the pursuit of magnetite nanoparticles which display 
superparamagnetism. 
 
2.3 Synthesis via co-precipitation 
2.3.1 Introduction 
The most widely used method of Magnetic nanoparticles in both laboratory and 
industrial synthesis is the co-precipitation method and involves the chemical co-
precipitation of iron salts 
44-46
. In this synthetic route magnetite (Fe3O4) is obtained 
from an aqueous solution of Fe(III) and Fe(II) salts in a molar ratio of 2:1 
17, 42
. The 
equation of this reaction is as follows: 
 
Fe
2+ + 2Fe3+ + 8OH- → Fe3O4+4H2O (1) 
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MNPs are obtained if the reaction environment is free of oxygen and non-oxidizing 
species, and also at a pH in the range of 8-14 
47
. This method is also popular due to 
the large yield of MNPs that is obtained, but its major flaw lies in the broad particle 
size distribution and this is due to the growth of the nanoparticles only being 
controlled by kinetic factors 
17
. 
 
2.3.2 Co-precipitation in literature 
In 1999, a publication by Babes et al. 
48
 reported the synthesis of iron oxide 
nanoparticles via the co-precipitation method. Some of the parameters that were 
varied during the study were the molar ratio of the ferric and ferrous salts, the 
composition of the basic solution used to initiate the formation and precipitation of 
the nanoparticles, the temperature, the amount of oxygen present in solution, as well 
as the stability of the nanoparticles. No surfactant or surface modification was 
included as part of the study. Transmission electron microscopy (TEM) of the 
nanoparticles indicated that the use of tetramethylammonium hydroxide (TMAOH) 
as the base produced large particles of prismatic morphology with an approximate 
size of 15 nm, while the smaller nanoparticles had more spherical shapes and 
approximate sizes of around 4 nm. However, combining TMAOH with ammonia 
yielded nanoparticles which were all angulated spheroids and had a much broader 
particle size distribution. The temperature was varied between 20 and 65 ˚C and it 
was found that the particles obtained showed decreases in size and relaxivity with 
increasing temperature. A sample of the nanoparticles was exposed to a magnetic 
field for 24 hours to test the infield stability and it was found that the relaxation rates 
remained unchanged after the 24 hour period and no induced agglomeration 
occurred. Results from outfield stability testing showed stability of the nanoparticles 
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for a minimum of one month. The variation of the ratio of ferric and ferrous salts in 
solution was limited to a range of 0/10 Fe(II)/Fe(III) and 8/10, and showed that 
particle size increased and yield (67.2 ± 4.6%) fell below the average percentage 
yield of approximately 85% with increasing molar ratio. Ratios of around 0.3 and 
≥0.4 yielded good results with stable nanoparticles being formed, whereas ratios 
greater than 0.7 gave rise to problems in electromagnetic filtration of the 
nanoparticles. It was then also deduced that nanoparticles obtained from molar ratios 
between 0.4 and 0.6 were best for application in MRI. To study the effects of 
oxygen, the reaction mixture were partially degassed in a nitrogen or argon stream. 
The yield of nanoparticles decreased from 84.4% to 75.5% when the reaction 
mixtures were degassed, but an increase in mean particle size increased from 4.3 nm 
to 5.5 nm. This study clearly showed how varying different parameters can lead to 
changes in the properties and yield of nanoparticles, however slight the change might 
be. 
 
In a recent publication, Saraswathy et al. also made use of co-precipitation as a 
means of MNP synthesis 
49
. Anhydrous FeCl3 was dissolved in solution with 
FeCl2·H2O in a 2:1 molar ratio. The reaction took place at 80 ˚C and precipitation 
was initiated with the addition of 1M NaOH to obtain a pH of 12 in the reaction 
mixture. The reaction was allowed to proceed for 2 hours to allow maximum 
precipitation of the nanoparticles. Thereafter, the nanoparticles were isolated 
magnetically, washed and the pH adjusted to allow adequate dispersion in water. The 
nanoparticles were then mixed with 3% dextran for 6 hours at 80 ˚C. The coated 
nanoparticles were then washed with deionized water and centrifuged. The 
morphology and crystal structure of the nanocrystals were analyzed using high 
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resolution TEM (HRTEM), X-ray diffraction (XRD) and dynamic light scattering 
(DLS). The micrograph obtained from HRTEM showed particles that were nearly 
spherical with an average particle size of 12 nm. The dispersity of the particles was 
attributed to the presence of the dextran, though the image included in the article 
does not correlate with this observation. The indices from the spectra of XRD 
analysis confirm that magnetite nanoparticles had formed while the DLS analysis 
concluded that the hydrodynamic diameter of the nanoparticles was 50 nm. The 
magnetic properties were analyzed using vibrational sample magnetometer (VSM) 
and MRI characterization techniques. The zero coercivity of the VSM analysis 
proves that the nanoparticles are superparamagnetic. The Ms values varied from 62.7 
emu/g for uncapped Magnetic nanoparticles and 45.87 emu/g for the capped 
Magnetic nanoparticles with a single magnetic domain was identified from this data. 
 
To date, the inclusion of dopants in the synthesis of magnetic nanoparticles requires 
a very simple change in the synthetic procedure. Depending on the selected route, 
the amount of iron precursor is reduced and replaced by the molar equivalent of the 
selected dopant. Liu et al. 
20
 reported on the synthesis and characterization of zinc-
doped nanoparticles with emphasis on the changes observed in the magnetic 
properties due to the presence of the dopant (Fig. 3). The coprecipitation route was 
used to prepare nanoparticles with the formula Znx Fe3-x O4 (x=0, 0.1, 0.2, 0.3, 0.4, 
0.6, 1.0). Samples of ferrous chloride tetrahydrate (FeCl2·4H2O), ferric chloride 
hexahydrate (FeCl3·6H2O) and zinc chloride were dissolved in distilled water and 
stirred under a nitrogen atmosphere to prevent unwanted oxidation of the Fe
2+
 ions in 
solution. Three separate surfactants were employed during synthesis, namely 
polyethylene glycol (PEG), 3-aminopropyltriethoxysilane (APTES) and sodium 
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dodecyl benzene sulfonate (SDBS). Each surfactant solution was added and 
vigorously stirred at 500 rpm with the solution heated to 30 ºC. After sufficient 
mixing had taken place, ammonium hydroxide (NH4OH) was added dropwise to the 
reaction mixture to induce formation of the nanoparticles. The pH of the solution 
was kept at 10 and the reaction allowed to proceed under the same conditions for 1 
hour. The temperature was then elevated to 80 ºC and the particles allowed to ripen 
for a further 3 hours. The nanoparticles were then isolated via decantation and the 
magnetic product washed with distilled water until a pH of 7 was reached. They 
were further washed thrice with ethanol and dried for 24 hours at 60 ºC in a vacuum 
oven. The resulting product was then ground with a pestle and mortar for 
characterization. Data collected from vibrating sample magnetometer analysis 
revealed linear increase in saturation magnetization up to 500 Oe followed by a 
gradual curved increase up to 2000 Oe and complete saturation at around 4400 Oe. 
Most importantly was the 37.75% increase in the saturation magnetization in zinc 
ferrite nanoparticles compared to the pure ferrite nanoparticles. This was observed 
for zinc ferrite with x=0.2, and is attributed to changes in the crystallite size, lattice 
spacing and superexchange interaction of atoms within the crystal structure. XRD 
data confirmed the formation of the face-centered cubic inverse spinel structure 
inherent in ferrites, with very little difference visible between the undoped and doped 
nanoparticles. The greatest diffraction intensity was observed for the (311) plane and 
was used for further studies of the nanocrystal structure. Calculation of average 
particle size using the Scherrer equation revealed an increase in size up to x=0.2 
followed by a decrease and another increase at x=1.0. Since the zinc ferrite with 
x=1.0 was excluded from VSM characterization, it is clear that x=0.2 is the doping 
limit for the nanoparticles prepared under the chosen conditions. 
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Figure 3:  Saturation magnetization curves for ZnxFe3-xO4 MNPs with increasing 
amounts of zinc dopant reported by Liu et al with (a) the original 
curves obtained at room temperature and (b) curves at 4400 Oe 
normalized by M(0). 
20
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2.4 Biomedical Applications 
2.4.1 Introduction 
The biomedical applications of nanotechnologies include use in controlled drug 
delivery, tissue engineering, biosensors and disease detection, amongst others 
50
. At 
the nanoscale, the two forms of iron oxide, namely magnetite and maghemite, are 
reported to be the most commonly used materials in biomedicine 
51, 52
. These 
materials are said to have the potential to revolutionize therapeutic techniques and 
clinical diagnostics 
53-57
.  
 
2.4.2 MNPs and biomedicine 
2.4.2.1 MRI 
As mentioned earlier in this work, one of the in vivo applications of magnetic 
nanoparticles is their use as MRI contrast agents for molecular and cell imaging. The 
distinction between unhealthy and healthy tissue is facilitate by magnetic 
nanoparticles which behave as a core in the contrast agent 
52
. Saraswathy et al made 
use of dextran coated magnetic nanoparticles as a contrast agent for the MRI of liver 
fibrosis 
49
. 
 
2.4.2.2 Drug delivery 
For more than 30 years, MNPs have been developed as next generation components 
in drug delivery due to their functionality at both cellular and molecular levels 
58,59
. 
The aim of this technique is to direct the drug to the exact location of the disease and 
deliver it without having any negative effects on the surrounding healthy tissue 
60
. 
Wang et al. 
61
 reported the successful preparation of block co-polymer coated MNPs 
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for the delivery of curcumin. The synthesis of block co-polymer coated MNPs for 
delivery of doxorubicin 
62
 has also been reported. 
 
2.4.3 MNPs and breast cancer research 
2.4.3.1 Breast cancer cell separation 
Another biomedical application is the use magnetic nanoparticles for the targeting 
and separation of cells from biological mixtures. It has been reported that before 
tumors are detected in the body, circulating tumor cells (CTCs) can be found in the 
blood stream 
63, 64
. The challenge arises in from the fact that blood contains 2.5-4 × 
10
8
 platelets, 3-10 × 10
6
 white blood cells and 3-9 × 10
9
 red blood cells per milliliter, 
whereas CTCs are only found in the range of 0-50 per milliliter of blood 
56
. Xu et al. 
67
 reported the cell separation capabilities of MNPs that were prepared via thermal 
decomposition and were found to be 27 ± 5 nm in size. The hydrophobic 
nanoparticles were made hydrophilic through the addition of a amphiphilic polymer 
over the hydrophobic surfactant, thus increasing the overall size to 33 nm. Carboxyl 
groups present in the surfactant allowed for bioconjugation with anti-HER2 via a 
covalent bond with an amine group in the antibody, which facilitates the targeting of 
the HER2 protein receptor tyrosine kinase that is over expressed on the surface of 
SK-BR3 breast cancer cells. The Dulbecco’s phosphate (DPBS), DPBS + bovine 
serum albumin (BSA), RPMI-1640, RPMI-1640 medium supplemented with 10% 
heat-inactivated fetal bovine serum(FBS) and 1% streptomycin/penicillin, and 
human plasma were used in testing the stability of the functionalized nanoparticles in 
biological media. Tests showed that the nanoparticles remained stable in all the 
above mentioned media, except RBPMI-1640 in which the nanoparticles 
precipitated. The specificity of the functionalized nanoparticles was tested in a buffer 
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solution after staining with Prussian blue. TEM was used to examine the activity of 
the nanoparticles after adding them to the cancer cell culture and it was found that 
the nanoparticles were highly attracted to the surface of the cell, and some were even 
drawn into the cancer cells via the endocytotic pathway and trapped within cellular 
vesicles (Fig. 4). Another study was carried out to examine the nanoparticle activity 
when exposed to the whole isolated HER2 receptor. Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) results showed that nanoparticles 
that were not conjugated to the antibody had no attraction to the HER2 receptor. 
However, the conjugated nanoparticles that were conjugated to the receptor caused 
lagging progression through the gel when combined with the SK-BR3 cell lysate and 
increasing concentrations of the isolated receptor. This further proved the efficiency 
and specificity exhibited by the conjugated nanoparticles. Finally, the nanoparticles 
were tested in samples of whole female human blood that had been mixed with the 
SK-BR3 cancer cells. The cell count for the commercial female human blood 
showed a total cell count of 4.2 × 10
7
 cells/mL with the red blood cell content 
measured to 4.4 × 10
9
 cells/mL. 300 SK-BR3 cells were stained with 5-
chloromethylfluorescein diacetate (CMFDA) and mixed with 1 mL of the whole 
blood to attain an approximate cancer cell to blood cell ratio of 1:10 000 000. The 
nanoparticles were introduced to the mixture and a permanent magnet was used to 
attract the cancer cells and nanoparticles out of the mixture. A sample of the 
conjugated nanoparticles and cancer cells were then examined under a microscope 
and the number of cancer cells was determined due to the larger size and difference 
in colouration. It was reported that a recover of up to 86% was observed with an 
average of 73.6% for all the tests performed. This proved how effective the 
nanoparticle systems were compared to current methods of cell separation. 
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Figure 4: TEM images reported by Xu et al 
67
 showing cancer cells stained with 
Prussian blue A) exposed to antibody-functionalized MNPs, B) 
exposed to MNPs with carboxyl functionalization, C) low 
magnification of cell section, D) partial magnification showing 
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exposure to antibody-functionalized MNPs and E) showing evidence 
of cellular uptake of antibody-functionalized MNPs. 
2.4.3.2 Breast cancer drug delivery 
One of the greatest problems in cancer therapy via chemotherapy methods is the lack 
of specificity in the targeting of tumor cells. Research work reported by Marcu et al 
68
 was based on this, in an attempt to overcome this problem. MNPs were prepared 
via laser pyrolysis of vapour precursors and coated with the VB1 drug. 
Monodispersed MNPs with an average particle size of 8-10 nm were reported in this 
study. The targeted cell line selected was that of human breast adenocarcinoma 
cancer, MCF-7. Cellular uptake of the drug coated nanoparticles was better in 
comparison to pure iron oxide MNPs of 20 nm due to the smaller size. Tests with 
free VB1 showed a more rapid decrease in cellular impedance and the appearance of 
apoptotic vesicles in the cancer cells compared to the coated nanoparticles, with the 
time taken reported as 10 hours for the free VB1 and a much longer time period for 
the coated MNPs (data not reported). This was attributed to the different endocytotic 
pathway taken by the coated MNPs when passing through the plasma membrane. 
 
2.4.3.3 Doped MNPs and breast cancer 
MNPs doped with manganese and zinc to yield particles with the formula 
Mn0.24Zn0.76Fe2O4 were reported by Latorre-Esteves et al 
69
. The co-precipitation 
route was used and nanoparticles with an average size of 15 nm were obtained and 
the superparamagnetic nature of the nanoparticles was also confirmed. Tests on the 
MCF-7 cell line showed no changes in the cell viability, therefore confirming that 
the biocompatibility of the MNPs was maintained after doping with magnesium and 
zinc. 
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2.5 Conclusion 
The literature discussed within this chapter is only a small fraction of the research 
that has been reported on the synthesis, characterization and applications of MNPs. 
Strong evidence is given for the use of MNPs in biomedical applications as well as 
the enhancing effects exhibited by the inclusion of dopants during synthesis. It is 
upon this foundation that the work discussed in the following chapters is built with 
the aim of preparing superparamagnetic zinc-doped iron oxide nanoparticles that are 
suitable for application in biomedicine. 
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Chapter 3 
 
 
Chapter Overview 
Chapter 3 gives a discussion of the methodology employed to prepared zinc-doped 
MNPs and the characterization techniques used to study the physicochemical 
properties of the as-prepared nanoparticles. 
 
3. Methodology 
3.1 Chemicals 
Anhydrous iron (III) chloride (FeCl3), iron (II) sulphate (FeSO4), 25% ammonium 
hydroxide (NH4OH) and polyethylene glycol (PEG) were used. 3-
phosphonopropionic acid (3-PPA) was purchased from Sigma Aldrich (South 
Africa). All reagents were of analytical grade. Preparation of all MNPs took place in 
the Nanomaterials and Organometallics Research Laboratory at the University of the 
Western Cape. 
 
3.2 Synthesis 
3.2.1 Procedure 
A novel synthetic procedure for the synthesis of zinc doped MNPs is presented. 
Preliminary experiments were carried out to test the co-precipitation method. The 
ferric and ferrous salts mentioned above were dissolved in deionized water with a 
known amount of PEG in a three neck round bottomed flask and flushed with 
nitrogen to prevent oxidation of the Fe(II) ions to Fe(III). The brown solution was 
heated to 50 °C, at which point a known amount of 25% NH4OH was slowly injected 
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into the flask to induce the formation of the nanoparticles. The product was left to 
ripen for two hours after which it was isolated via magnetic decantation and taken 
for characterization. 
 
Doped Fe3O4 nanoparticles with the formula ZnxFe3-xO4 (x = 0, 0.1, 0.2, 0.3, 0.4) 
were prepared via the co-precipitation method. The formation of the doped MNPs is 
represented by the following balanced chemical equation: 
 
Znx
2+
 (aq) + Fe1-x
2+
 (aq) + 2Fe
3+
 (aq) + 8OH
-
 (aq) → ZnxFe3-xO4 (aq)+ 4H2O(l)      (2) 
 
The amount of dopant added for each value of x was controlled in such a manner as 
to keep the ratio of trivalent and divalent metal cations at 2:1. To improve 
dispersibility, 3-phosphonopropionic acid (3-PPA) was introduced as a capping 
agent. In a typical synthesis of doped MNPs, weighed samples of anhydrous ferric 
chloride (FeCl3), ferrous sulphate (FeSO4) and hydrated zinc chloride (ZnCl2·4H2O) 
were dissolved in deionized water and stirred magnetically to obtain a homogenous 
mixture. The flask was flushed with nitrogen and heated to 40 ˚C and the reaction 
mixture stirred at 400rpm for the duration of the reaction. A known volume of 25% 
ammonium hydroxide (NH4OH) was slowly injected into the flask to induce co-
precipitation and formation of the nanoparticles. After ripening for 30 minutes, the 3-
PPA that was dissolved in water was injected into the reaction mixture. This was 
done to prevent an unwanted reaction between the NH4OH and the 3-PPA. The 
nanoparticles were then allowed to ripen for a further 30 minutes before isolation 
and purification. 
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3.2.2 Isolation and purification 
The as-prepared zinc ferrite nanoparticles were isolated via magnetic decantation. 
The precipitate solid product was washed with deionized water and ethanol to 
remove excess NH4OH and 3-PPA. The supernatant liquid obtained from magnetic 
decantation contained both the reducing and capping agents and was disposed of as 
toxic waste. 
 
3.2.3 Sample preparation 
3.2.3.1 HRTEM and EDS 
Samples were dispersed in deionized water for analysis. The samples were then 
deposited onto the required platform for characterization. 
 
3.2.3.2 XRD, FTIR, TGA ,and SQUID 
Samples were dried in a vacuum oven at 60 °C for 24 to 36 hours. Once sufficient 
drying had taken place, a pestle and mortar was used to grind the solid material into 
a fine powder. Samples were divided, labeled and taken or sent for analysis. 
 
3.3 Characterization 
3.3.1 HRTEM 
High resolution transmission electron microscopy (HRTEM) was used to 
characterize the morphology, size and dispersion of the nanoparticles. In this 
technique, a high energy electron beam is generated from an electron source and 
focused onto the sample which is deposited onto a small metal grid, as seen in Fig. 5. 
The electron beam is necessary to observe materials with morphological features in 
the nanoscale and is focused onto a point on the sample grid by magnets arranged 
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along the path of the beam. As the name of this technique suggests, the beam is 
transmitted through the sample, and changes in the energy of the electrons is 
detected and converted by sophisticated software to generate an image of the 
material. For the characterization of the ZnxFe3-xO4 nanoparticles (x=0, 0.1, 0.2, 0.3, 
0.4), samples were dispersed in deionized water and dropped onto a copper grid. The 
grid was allowed to dry in air before being inserted into the microscope. An FEI 
Tecnai
TM
 F30ST field emission gun transmission electron microscope (FEG-TEM), 
operated at an accelerating voltage of 200 kV in bright-field mode was used in this 
study. 
 
 
Figure 5: Schematic of the components of a standard HRTEM instrument 
1
. 
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3.3.2. XRD 
The identification of the crystal structure of a material is important for confirming 
that the correct material has been synthesized. X-ray diffraction spectroscopy is a 
technique in which an organic or inorganic sample 
2
 is exposed to monochromatic X-
rays generated from a cathode ray tube. As the X-rays enter the sample, they 
encounter the atoms arranged within the crystal structure, and are diffracted out of 
the sample material as seen in Fig 6. 
 
Figure 6: A schematic diagram showing X-rays interacting with a crystal 
structure in XRD analysis 
3
. 
 
Bragg’s Law shows the relationship between the wavelength of the X-ray, λ (nm), 
the lattice spacing, d (nm) and the diffraction angle, θ (°): 
 
nλ = 2dsinθ (3) 
where n is the order. 
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The diffracted X-rays are detected by the instrument and software is used to convert 
the data into spectra. Peaks that appear in the spectrum can be attributed to the X-
rays interacting with specific domains of the crystal structure and can be compared 
to fingerprints in the identification and confirmation of materials. One advantage of 
this technique is that samples are not lost or destroyed and can be taken collected and 
used elsewhere after characterization.  
 
For the determination of the crystal structure of the undoped and doped nanoparticles 
presented in this work, samples in a dry, powdered form were characterized in a 
Bruker AXS D8 Advance Diffractometer (Germany) fitted with a PSD Vantec-1 
detector. A Cu-Kα (λKα1 = 0.15406 nm) radiation source was used. The selected 
range for 2θ was 20-70° with an increment of 0.02°. OriginPro 8 software was used 
to convert the raw data obtained. 
 
3.3.3 EDS 
Elemental analysis of samples confirms the presence of the desired elements within 
the sample and also reveals the presence of any impurities. This technique is 
performed on samples after characterization with HRTEM. Upon exposure to the 
electron beam, the electrons within the sample are excited to a higher energy level, 
and release X-rays as they return to the ground state 
4
. The wavelength of each X-ray 
is unique to the element from which it was emitted, and this is then detected and 
used to identify the elements present in the sample and also yields data on the 
percentage abundance of the elements within the sample. The EDS spectra were 
collected with a liquid nitrogen cooled EDAX SiLi detector. Each spectrum was 
collected for 30 seconds. 
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3.3.4 FTIR 
The use of surfactants in nanoparticle synthesis requires the use of a technique to 
confirm that the surfactant is indeed linked in some way to the surface of the 
nanoparticle. In FTIR, the sample is placed between the beam splitter 
(interferometer) and the detector, as seen in Fig. 7. An interferogram, or spectrum, is 
generated by subtracting the spectrum of the sample from that of the continuous light 
source. An interferogram of the solvent is collected first, followed by the analyte 
dissolved in the solvent as required. The spectrum of the sample that is generated by 
the instrument is the result of the division of the second interferogram by the first 
5
. 
To determine whether 3-PPA was bonded to the surface of the nanoparticle a Perkin 
Elmer Spectrum2 was used. Both the capped and uncapped nanoparticles of x=0.2 
were characterized by grinding the dry sample with KBr and compressing the 
powder to form a pellet. 
 
 
 
Figure 7: A basic schematic representation of the components of an IR 
spectroscopy instrument 
6
. 
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3.3.5 TGA 
Supporting data that proves the presence of the surfactant at the particle surface can 
be obtained from thermogravimetric analysis (TGA). In this analysis, a small amount 
of sample is placed in a crucible which is heated over a selected temperature range. 
As the temperature increases, volatile components within the sample will escape 
from the crucible, thus decreasing the mass 
7
. A plot of weight percentage versus 
temperature reveals a curve showing progressive loss of mass as the temperature 
increases and can be used to determine what components of the sample were lost. A 
sample of 3-PPA and a sample of3-PPA-capped Zn0.2Fe2.8O4 were analyzed with this 
technique using a Perkin Elmer TGA4000. The sample analysis was done under air 
and the decomposition measured over a temperature range of 30-900 °C. 
 
3.3.6 Zeta Potential 
Zeta potential measurements are based on the fact that colloidal particles possess a 
positive or negative electrostatic charge 
8
. When an electric field is applied to the 
particle dispersion, the particles migrate in opposite directions depending on their 
charge with respect to the direction of the field. When the particles are irradiated in 
the process of migration they scatter light causing a Doppler shift which is dependent 
on the electrophoretic mobility shift of the colloids. The zeta potential calculation is 
based on the Smoluchowski equation which takes into account electrophoretic 
mobility, permittivity and viscosity of the colloid particles. The zeta potential of a 
sample can be determined by diluting a solvent with known properties (viscosity, 
dielectric constant and refractive index). The nanosizer is connected to a nanoplus 
(titrator) fitted with both acid and basic solution purposely to adjust the pH of the 
sample automatically. For this analysis, a NanoPlus AT titrator was used. A pH of 8 
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was selected for analysis of the zeta potential using 0.1 M solutions of sodium 
hydroxide (NaOH) and hydrochloric acid (HCl) as standards for adjusting the pH. 
 
3.3.7 SQUID 
Superconducting quantum interference device (SQUID) analysis is used to 
characterize the magnetic properties of a given material. The two main properties of 
superconductors, namely the Josephson effect and flux quantization are applied to 
measure small changes in the magnetic field of the superconductor while 
characterizing a sample 
9
. The sample is place into the instrument and exposed to a 
magnetic field that increase from negative to positive to yield the saturation 
magnetization (Ms) of the sample (Fig. 8). This also reveals whether the material is 
ferromagnetic or paramagnetic depending on whether hysteresis is observed in the 
curves that are generated. Sample of ZnxFe3-xO4 (x = 0, 0.1, 0.2, 0.3, 0.4) were 
characterized using a Quantum Design XL-7 SQUID Magnetometer (San Diego). 
The saturation magnetization was measured as a function of the magnetic field up to 
30 000 Oe at 25 °C. 
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Figure 8: Basic schematic of the inner workings of a SQUID magnetometer. 
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Chapter 4 
 
 
Chapter Overview 
Chapter 4 contains a brief discussion of the synthesis of undoped and doped zinc 
ferrite MNPs with emphasis on the results obtained from all the characterization 
techniques employed to analyse the NPs. 
 
4. Results and Discussion 
4.1 Synthesis 
Both the undoped and doped MNPs were successfully prepared in this research. 
Some product was lost due to magnetic attraction to the stirrer bar used during 
synthesis, but the amount lost is small enough to be negligible. Fig. 9 shows pure 
Fe3O4 nanoparticles dispersed in deionized water. In Fig. 9.(a,b), and the 
nanoparticles from the same batch after exposure to a magnet. After being left for 
several minutes, the deionized water was completely clear as all the nanoparticles 
were attracted to the magnet. The same behaviour was observed for the doped 
nanoparticles tested in the same way (Fig. 9.(c,d)). 
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Figure 9: a) Pure iron oxide MNPs (x=0) and c) doped MNPs (x=0.2) 
suspended in deionized water. Attraction to an external magnetic field 
is seen in b) and d). 
 
4.2 HRTEM 
Figure 10 shows micrographs obtained from the HRTEM characterization of 
uncapped iron oxide MNPs (Fig. 10.(a)) and MNPs capped with PEG (Fig. 10.(b)) 
synthesized in preliminary experiments. In both cases, the nanoparticles have 
spheroidal morphology. The lack of a capping agent is evident as the nanoparticles 
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appear highly agglomerated. The addition of PEG greatly improves the dispersion of 
the nanoparticles, as can be seen in Fig. 10.(b).  
 
  
Figure 10: a)Uncapped iron oxide MNPs and b) PEG capped iron oxide MNPs 
synthesized in preliminary experiments. 
 
Fig. 11 shows the HRTEM micrograms obtained from the characterization of the 
zinc-doped MNPs. The magnetic nanoparticles (MNPs) showed similar spheroidal 
morphology with and without the addition of the 3-PPA. The nanoparticles showed a 
high level of agglomeration without and with the inclusion of the 3-PPA surfactant. 
This could be due to an insufficient amount of surfactant relative to the amount of 
nanoparticles produced, and in turn, this led to challenges in estimating the particle 
size from the micrographs. 
 
It was also seen that the presence of the zinc dopant had no visible effect on the 
morphology of the nanoparticles. This indicates that the dopant atoms assimilated 
easily within the crystal structure of the nanoparticles. Closer inspection of the 
MNPs showed the presence of lattice lines indicating high levels of crystallinity. 
This further proves that the zinc dopant was incorporated into the crystal structure 
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without causing physical irregularities. Estimation of particle sizes from HRTEM 
micrographs proved challenging due to the agglomeration of the nanoparticles. Fig 
11.c) and 11.d) shower particle sizes for Zn0.1Fe2.9O4  and Zn0.4Fe2.6O4 with average 
particle sizes of 10.23 nm and 9.26 nm respectively. These estimates are not 
completely reliable due to the agglomeration visible in micrographs, thus there is 
room for error in the particle size determination. 
 
 
 
 
 
Figure 11: HRTEM micrographs of a) doped MNPs (x=0.1), b) doped MNPs 
(x=0.4) and their respective particle size distributions in c) and d). 
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4.3 XRD 
The XRD spectra obtained for the undoped and doped MNPs is given in Fig. 12 
below. The peaks that appeared were attributed to the crystal planes indexed at 
(220), (311), (400), (422), (511), and (440). This confirms the formation of the 
inverse spinel structure of magnetite. The peak indexed at (311) was used to estimate 
the average particle size for undoped and doped nanoparticles as can be seen in Tab. 
1. by application of the Scherrer equation: 
 
d(311) = kλ/βcosθ (4) 
 
It was found that the particle sizes showed a slight increase in size as the amount of 
zinc dopant increased from x=0 and reaching a maximum at x=0.2. Beyond this, the 
particle decreased through x=0.3 and x=0.4. This could be due to the MNPs 
approaching a doping limit at x=0.2 where the particle size and physicochemical 
properites reach a maximum value. 
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Figure 12: The XRD spectra for nanoparticles with the composition of ZnxFe3-xO4 (x 
= 0, 0.1, 0.2, 0.3, 0.4). 
 
Table 1: Particle size determined from XRD data and the Scherrer equation 
 2θ θ radians cosθ λ 
(nm) 
FWHM β radians d(311) 
(nm) 
x=0 
36.623 18.3115 0.3196 0.949361 0.154 1.7576 0.8788 0.01534 
 
9.41 
x=0.1 
35.6504 17.8252 0.3111 0.951997 0.154 1.7302 0.8651 0.0151 
 
9.52 
x=0.2 
35.5131 17.75655 0.3099 0.952364 0.154 1.5379 0.76895 0.01341 
 
10.73 
x=0.3 
35.4857 17.74285 0.3096 0.952456 0.154 1.7027 0.85135 0.01486 
 
9.68 
x=0.4 
35.4307 17.71535 0.3092 0.952577 0.154 1.7302 0.8651 0.0151 
 
9.53 
 
4.4 FTIR 
The spectra obtained from FTIR analysis can be seen in Fig. 4. In the spectrum of the 
uncapped nanoparticles (Fig. 4.(a)), the strong stretching band for the Fe-O within 
the nanoparticle crystal structure is visible at 578 cm
-1
. The broad stretching band for 
–OH bonds is observed at 3394 cm-1 and is attributed to water molecules adsorbed to 
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the surface of the uncapped nanoparticles. The small peak at 1619 cm
-1
 could be 
attributed to the C=O stretch of carbon dioxide within the instrument. The change in 
percentage transmittance was a good indication that capping with 3-PPA had taken 
place. The capped nanoparticles (Fig. 4.(b)) showed a similar Fe-O stretching band 
at 588 cm
-1
. The band observed at 992 cm
-1
 and 1103 could be attributed to the 
stretching of P-O bonds. The small band observed at 1391 cm
-1
 could be attributed to 
the bending of C-O-H while the band at 1629 cm
-1
 could be attributed to the 
stretching frequencies of C=O in the carboxylate group. The broad band at 3404 cm
-1
 
could be attributed to the stretching band of O-H bonds in both the phosphate and 
carboxylate groups. Kalska-Szostko et al 
1
 reported the successful synthesis of iron 
oxide nanoparticles with 3-PPA as the surfactant, and their work was used to 
corroborate the findings of the FTIR analysis in this research. This shows that 
linkage of the 3-PPA to the nanoparticle takes place via the P=O in the phosphate 
group and iron atoms at the surface of the particle and that successful capping had 
been achieved. 
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Figure 13: FTIR spectra of the (a) uncapped and (b) capped Zn0.2Fe2.8O4 
nanoparticles. 
 
4.5 TGA 
Fig. 14 shows the thermal decay of 3-PPA and 3-PPA capped zinc ferrite 
nanoparticles with x=0.2. For 3-PPA (Fig. 14.(a)) it is seen that from 30 °C to 156 °C 
there is an increase in mass. This is due to the hygroscopic nature of 3-PPA with 
water molecules accumulating in the sample while still at relatively low 
temperatures. From 156-900 °C a three-step decomposition can be seen. From 156 
°C to approximately 375 °C there is a steep decrease in mass from 102% to 75%. 
This could be due to loss of the adsorbed water as well as the other components of 
the compound such as the phosphate (-PO(OH)2) group. The second loss of mass is 
observed from 375 °C to 540 °C which could be due to the loss of the carboxylate (-
COOH) group. The remnants of the 3-PPA resembled amorphous carbon. It is 
possible that this material might only decompose at temperatures beyond 900 °C. 
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The 3-PPA capped nanoparticle (Fig. 14.(b)) showed a very small decrease in mass, 
but this is due to the very small amount of 3-PPA bonded to the surface relative to 
the mass of the nanoparticles. The slow loss of mass from 30 °C to approximately 
410 °C could be due to the slow release of the -PO(OH)2 group. The almost linear 
decrease which follows from 410 °C to 900 °C could be due to the loss of the 
carboxylate group. The differences between the two curves could be attributed to the 
nanoparticles having a catalytic effect on the thermal decomposition of the 3-PPA. 
Jurikova et al. reported the catalytic effect of iron oxide MNPs on the thermal 
decomposition of dextran, and it is likely that the same effect is being observed here 
2
. This supports the FTIR analysis in confirming successful capping of 3-PPA onto 
the nanoparticles. 
 
 
Figure 14: The thermal decomposition curves for (a) 3-PPA and (b) 3-PPA  
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4.6 EDS 
The EDS analysis was used to study elemental composition of the nanoparticles with 
results visible in Fig. 15(a,b). The spectra obtained for the undoped and uncapped 
MNPs indicated the presence of iron and oxygen with a percentage abundance of 
42.03% and 20.02% respectively. The same test was performed on doped and capped 
MNPs. For x=0.2 peaks for iron, oxygen and zinc were observed with percentage 
abundance of 12.33%, 24.94%, 0,97% respectively, while the presence of the 
phosphorous in the surfactant was not observed. For x=0.4 peaks for iron, oxygen, 
zinc and phosphorous were observed with percentage abundance of 13.22%, 32.93%, 
2.42% and 0.37% respectively. The peaks for copper and carbon that were observed 
were due to the grid onto which the samples were deposited for analysis and the 
carbon support structure which forms part of the grid. From this data it can be seen 
that the percentage abundance is not in agreement with the formulae of the 
respective MNPs. This inconsistency, along with the absence of peaks for 
phosphorous for MNPs with x=0.2 could be affected by factors such as non-
homogeneity within the reaction mixture as well as the effect of size differences in 
the particles onto which the instrument had focused to capture the micrograph. The 
agglomeration of the MNPs visible in the images could also cause inconsistencies in 
the elemental analysis. However, since this technique only yields data on a very 
small area of the sample, it cannot be assumed that the obtained percentage 
abundance is applicable to the entire sample. 
 
 
 
 
 
51 
 
 
Figure 15a): EDS spectrum of Zn 0.1 Fe2.9O4 MNPs 
 
a) 
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Figure 15b): EDS spectrum of Zn0.4Fe2.6O4 
 
4.7 Zeta Potential 
Zeta potential measurements were made to analyse the surface charge of the MNPs. 
A pH of 8 was selected for analysis. Uncapped iron oxide MNPs (x=0), as well as 
iron oxide MNPs (x=0) and doped MNPs (x=0.2) capped with 3-PPA were 
characterized with this technique, and the zeta potentials obtained were 0.32 mV,      
-0.87mV and -0.076 mV respectively. At low pH values, iron oxide MNPs are 
reported to have a negative zeta potential in water 
3
. The positive value obtained for 
the uncapped iron oxide MNPs (x=0) could be due to localized inhomogeneity 
within the solvent after pH adjustment by the instrument. A positive zeta potential in 
a basic environment is not common and requires further investigation. The negative 
values measured for the remaining two samples confirm successful capping with 3-
b)  
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PPA and are brought about by the ionization of –C=O to –C-O- in the carboxyl 
group. 
 
4.8 SQUID 
The saturation magnetization (Ms) for ZnxFe3-xO4 (x = 0, 0.1, 0.2, 0.3, 0.4) was 
characterized using SQUID analysis with the magnetization curves shown in Fig. 16. 
The lack of hysteresis loops in the curves for all the five samples indicates that 
superparamagnetic behaviour is inherent at all doping levels (x=0 to x=0.4). At x=0 
the nanoparticles exhibit saturation of 68.50 emu/g. The value of Ms observed for 
x=0.1 and x=0.2 were 72.08 emu/g and 73.37 emu/g respectively. For x=0.3 
saturation was observed at 63.65 emu/g and for x=0.4 saturation was reached at 
66.32 emu/g. 
 
Results reported by Liu et al. 
4
 show a similar trend in which the saturation 
magnetization increased from x=0, starting at 52.34 emu/g and reached a maximum  
at x=0.2 with a value of 80.93 emu/g, followed by a decrease as the x values 
increased. At x=0.4 the saturation magnetization had decreased below the 43.14 
emu/g. In comparison, the trend observed in Fig. 16 deviates at x=0.4 where the 
saturation increased instead of exhibiting a further decrease. An important 
observation is made when the Ms values from Fig. 16 are compared to the particle 
sizes determined by the Scherrer equation as seen in Table 1. The saturation 
magnetization and particle size increase from x=0 to x=0.2, followed by a consistent 
decrease in particle size, with the exception of the increased magnetization at x=0.4. 
The maximum reached at x=0.2 was expected, based on the work of Liu et al , and 
confirms that x=0.2 is the doping limit for zinc ferrite nanoparticles. The deviation 
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from the relation observed in particle size and saturation magnetization at x=0.4 
could be due improved distribution of the Zn(II) cations within the crystal structure 
in comparison to doping at x=0.3. During synthesis, there is no control over the 
placement of dopant ions within the crystal structure, only the dopant concentration. 
However, consistency in this trend requires further investigation. The saturation 
magnetizations of the nanoparticles presented in this work were higher than that for 
the reported value of pure iron oxide MNPs. At x=0, the value is higher than the 
reported value of 50 emu/g 
5
, highlighting the effectiveness of the synthetic 
procedure. It is possible that higher values can be obtained if the ripening period is 
extended, since higher saturation was reported by Liu et al, especially at x=0.2. The 
improved magnetic properties obtained form doping could lead to more efficient and 
fast acting biomedical systems in which MNPs are used. 
 
Figure 16: Field-dependent magnetization at room temperature of ZnxFe3-xO4 for 
increasing amounts of zinc. 
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Chapter 5 
 
 
Chapter Overview 
In this chapter, conclusions are made based on the experimental data discussed in 
Chapter 4, followed by future work and recommendations. 
 
 
5. Conclusion and Recommendations 
5.1 Conclusions 
In conclusion, zinc-doped iron oxide MNPs were successfully prepared via co-
precipitation. This route was a one-pot synthetic approach in which an aqueous 
solution of both ferric and ferrous salts with zinc as the dopant and 3-PPA as the 
surfactant was used to prepare iron oxide MNPs. The effects of the zinc doping on 
the physical and chemical properties of the nanoparticles was then investigated. 
Analysis with HRTEM and XRD showed that particles of between approximately 
9.5 and 10.5 nm in size were obtained. The enhancement of the saturation 
magnetization and the relation to particle size were observed upon doping with zinc. 
The Ms value of 73.3 emu/g and maximum size of approximately 10.5 nm observed 
at the doping level x=0.2 leads to the conclusion that this is the doping limit for zinc 
ferrite. Capping with 3-PPA was confirmed with FTIR, TGA and zeta potential, but 
little change was observed in the agglomeration of the nanoparticles with or without 
 
 
 
 
56 
 
the surfactant. Some work remains to fully improve the MNP system described in 
this work, but the data collected so far indicates that these nanoparticles have great 
potential for application in the diagnosis and/or treatment of breast cancer. 
5.2 Recommendations 
Synthesis via the co-precipitation route opens up multiple routes for further 
investigation. The following work is proposed for further investigation: 
 Varying the pH during synthesis 
 Varying surfactant concentration 
 Varying reaction temperature 
 Characterization of the elemental composition using inductively-coupled 
plasma optical emission spectroscopy (ICP-OES) 
 Bioconjugation with a known anti-body and/or drug for the targeting and/or 
treatment of breast cancer 
 Separation of breast cancer cells using bioconjugated MNPs 
 Repeat of the separation study using zinc-doped MNPs 
 Validation of the separated cells to confirm successful targeting and 
separation by MNPs 
 
 
 
 
 
 
